PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency - Montaldi, Ana P.; Lima, Sarah Caroline Gomes de; Godoy, Paulo Roberto D'Auria Vieira; Xavier, Danilo Jordão; Sakamoto-Hojo, Elza Tiemi (Oncology Reports, 2020)